Showing results (101-110 of 118) with videos related to
Sort By:
Pageof 12
Proceedings of the National Academy of Sciences of the United States of America|July 27, 2022
A highly efficacious live attenuated mumps virus-based SARS-CoV-2 vaccine candidate expressing a six-proline stabilized prefusion spikeYuexiu Zhang, Mijia Lu, K C Mahesh, et al.Journal of Virology|January 26, 2022
Evaluating Antibody Mediated Protection against Alpha, Beta, and Delta SARS-CoV-2 Variants of Concern in K18-hACE2 Transgenic MiceTing Y Wong, Alexander M Horspool, Brynnan P Russ, et al.Cell|December 29, 2022
SARS-CoV-2 replication in airway epithelia requires motile cilia and microvillar reprogrammingChien-Ting Wu, Peter V Lidsky, Yinghong Xiao, et al.Nature Communications|July 3, 2024
Three SARS-CoV-2 spike protein variants delivered intranasally by measles and mumps vaccines are broadly protectiveYuexiu Zhang, Michelle Chamblee, Jiayu Xu, et al.Proceedings of the National Academy of Sciences of the United States of America|March 10, 2021
A safe and highly efficacious measles virus-based vaccine expressing SARS-CoV-2 stabilized prefusion spikeMijia Lu, Piyush Dravid, Yuexiu Zhang, et al.Proceedings of the National Academy of Sciences of the United States of America|October 5, 2023
A next-generation intranasal trivalent MMS vaccine induces durable and broad protection against SARS-CoV-2 variants of concernJiayu Xu, Yuexiu Zhang, Panke Qu, et al.Nature Communications|July 7, 2022
Characterization of SARS-CoV-2 Spike mutations important for infection of mice and escape from human immune seraRaveen Rathnasinghe, Sonia Jangra, Chengjin Ye, et al.Plos Pathogens|March 31, 2025
Enhanced RNA replication and pathogenesis in recent SARS-CoV-2 variants harboring the L260F mutation in NSP6Taha Y Taha, Shahrzad Ezzatpour, Jennifer M Hayashi, et al.Biorxiv : the Preprint Server for Biology|June 23, 2021
Anticancer pan-ErbB inhibitors reduce inflammation and tissue injury and exert broad-spectrum antiviral effectsSirle Saul, Marwah Karim, Luca Ghita, et al.The Journal of Clinical Investigation|August 15, 2023
Anticancer pan-ErbB inhibitors reduce inflammation and tissue injury and exert broad-spectrum antiviral effectsSirle Saul, Marwah Karim, Luca Ghita, et al.Pageof 12